In today’s newsletter, House Committee approves MORE Act, losses and layoffs in the industry, a useful video on 280(e), and more.
The House Judiciary Committee Approves MORE Act 24-10.
In a recent case before the U.S. Tax Court, the Court rejected a challenge to Section 280E disallowing business-related expenses connected to the trafficking of Schedule I controlled substances based on the Eighth Amendment.
Tilray reports large third-quarter losses related in large part to lower cannabis prices.
Leafly announces a certified labs program with the hope of combating inconsistency in cannabis testing.
More layoffs for California cannabis businesses, but optimism remains as the potential of a federal banking bill by year’s end has heightened lender interest.
This short video regarding the effects and history of 280e was informational.